Dear researchers,

Innovative Medicines Initiative 2, which is a programme jointly funded by medical companies and the EU has published the call topics for 2020.

Applications for IMI2 requires a consortium with a minimum of 3 partners from EU/Associated countries. Also SMEs can be partners and will get funding through the programme.

If you are interested in these topics, send me a message and I will help you out.

More detailed info:

https://www.imi.europa.eu/sites/default/files/uploads/documents/apply-for-funding/future-topics/FutureIMICallTopics_July2019.pdf

Neurodegeneration and other neuroscience priorities

• Digital endpoints and placebo effect in chronic pain

Infection control including vaccines

• Development of innovative personalized diagnostics and patient-guided therapies for the management of sepsis-induced immune suppression

Big data, digital health, clinical trials and regulatory research

• Data lakes

Oncology

• Prospective real-world clinical implementation of liquid biopsies;
• Tumour plasticity

Facilitating the translation of advanced therapies to patients in Europe

• Optimising patient access to new therapies for rare diseases

Best regards,

Emma

************************

Emma Pirilä, PhD

Research Funding Specialist

Faculty of Medicine

Faculty of Biochemistry and Molecular Medicine

Biocenter Oulu

Aapistie 5A, 2nd floor

FIN- 90230 University of Oulu

Finland

Phone: +358503426428

e-mail: emma.pirila@oulu.fi

************************